TREA

90191738 - ADCT

Follow

Information

  • Trademark
  • 90191738
  • Serial Number
    90191738
  • Filing Date
    September 18, 2020
    4 years ago
  • Transaction Date
    July 12, 2024
    5 months ago
  • Status Date
    July 12, 2024
    5 months ago
  • Published for Opposition Date
    May 24, 2022
    2 years ago
  • Location Date
    July 19, 2022
    2 years ago
  • Status Code
    733
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    EULIN, INGRID C
  • Attorney Docket Number
    3309.0070001
    Attorney Name
    TRACY-GENE G. DURKIN
    Law Office Assigned Location Code
    L50
  • Owners
Information
Mark Drawing Code
4
Mark Identification
ADCT
Case File Statements
  • GS0051: Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for use in the prevention and treatment of cancer and tumors; pharmaceutical preparations for use in the prevention and treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, pharmaceutical antibodies; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations, biological preparations, and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and substances for conditioning patients to receive therapies for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic agents, preparations, and substances for medical purposes; reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays to test tissue for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic kits comprised of medical diagnostic reagents and assays to test bodily fluids for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; medical diagnostic assays for testing body fluids; medical diagnostic assays for testing body tissue; diagnostic kits comprised of medical diagnostic assays to test for cell expressions for use in identifying pharmaceutical preparations and therapies for treating medical diseases, disorders, and conditions in humans
  • GS0441: Providing medical information; providing information in the fields of healthcare, therapeutic properties of pharmaceuticals, health, and wellness
  • GS0421: Pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; Providing medical and scientific research information in the fields of clinical trials; scientific study and research in the field of pharmaceuticals for the treatment of cancer
Case File Event Statements
  • 9/22/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 10/28/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/3/2021 - 3 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/2/2021 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/3/2021 - 3 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/3/2021 - 3 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/3/2021 - 3 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/3/2021 - 3 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/3/2021 - 3 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/6/2021 - 3 years ago
    10 - FINAL REFUSAL WRITTEN Type: CNFR
  • 10/6/2021 - 3 years ago
    11 - FINAL REFUSAL E-MAILED Type: GNFR
  • 10/6/2021 - 3 years ago
    12 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 4/6/2022 - 2 years ago
    13 - EXPARTE APPEAL RECEIVED AT TTAB Type: EXAF
  • 4/6/2022 - 2 years ago
    15 - EX PARTE APPEAL-INSTITUTED Type: EXPI
  • 4/6/2022 - 2 years ago
    16 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 4/11/2022 - 2 years ago
    17 - ASSIGNED TO LIE Type: ALIE
  • 4/6/2022 - 2 years ago
    14 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT
  • 4/12/2022 - 2 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/12/2022 - 2 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/20/2022 - 2 years ago
    21 - EXPARTE APPEAL TERMINATED Type: EXPT
  • 4/20/2022 - 2 years ago
    20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/4/2022 - 2 years ago
    22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/19/2022 - 2 years ago
    25 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 1/18/2023 - a year ago
    27 - SOU EXTENSION 1 FILED Type: EXT1
  • 5/24/2022 - 2 years ago
    23 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/24/2022 - 2 years ago
    24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/18/2023 - a year ago
    26 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/18/2023 - a year ago
    28 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 1/20/2023 - a year ago
    29 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/13/2023 - a year ago
    31 - SOU EXTENSION 2 FILED Type: EXT2
  • 7/13/2023 - a year ago
    32 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 7/13/2023 - a year ago
    30 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/16/2024 - 11 months ago
    34 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/16/2024 - 11 months ago
    35 - SOU EXTENSION 3 FILED Type: EXT3
  • 1/16/2024 - 11 months ago
    36 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 1/18/2024 - 11 months ago
    37 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/12/2024 - 5 months ago
    38 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/12/2024 - 5 months ago
    41 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/12/2024 - 5 months ago
    40 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 7/12/2024 - 5 months ago
    39 - SOU EXTENSION 4 FILED Type: EXT4
  • 7/15/2023 - a year ago
    33 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA